Calian Group (CGY) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
2 Apr, 2026Business overview and market position
Over 40 years of history with a workforce of 5,800 and a market cap of $542M, headquartered in Ottawa.
FY24 revenues reached $747M, with 49% from commercial and 51% from government customers.
Revenue segmentation: 29% ITCS, 28% Advanced Technologies, 28% Health, 15% Learning.
68% of revenues are Canadian, 32% international; 70% services, 30% products.
Key customers span defence, space, health, and government sectors, including major global and Canadian organizations.
Industry tailwinds and growth drivers
Defence, space, and health sectors are experiencing strong growth due to increased spending, technological advancements, and demographic trends.
Defence revenues have grown at a 14% CAGR, reaching $363M in LTM Q2-25, representing 49% of total revenues.
Significant exposure to defence through ITCS, Health, Advanced Tech, and Learning segments.
Financial performance and execution
Double-digit revenue and adjusted EBITDA CAGR since 2017; FY24 revenues at $747M and adjusted EBITDA at $92M.
Strategic plan targets $1B in revenues and $125M in adjusted EBITDA by FY26, driven by organic and acquisition growth.
Recent acquisitions (Decisive, MDA Nuclear Assets, Mabway, AMS) contributed to 53% of revenue and 59% of EBITDA targets.
Short-term headwinds in ITCS due to cost pressures, delayed procurement, and investments for future growth.
Latest events from Calian Group
- Record Q1 revenue and EBITDA growth, driven by Defence & Space and acquisitions, support strong outlook.CGY
Q1 202616 Apr 2026 - Defence revenues hit $373M with a $1B backlog, driven by new contracts and acquisitions.CGY
Investor presentation2 Apr 2026 - Sustained double-digit growth, strong cash flow, and strategic acquisitions drive value.CGY
Investor presentation2 Apr 2026 - Defence revenues hit $330M in FY24, driven by global expansion and portfolio strength.CGY
Investor presentation2 Apr 2026 - On track for $1B revenue by FY26, fueled by strong growth, M&A, and diversified segments.CGY
Investor presentation2 Apr 2026 - On track for $1B revenue by FY26, with robust growth, strong M&A, and raised FY24 EBITDA guidance.CGY
Investor presentation2 Apr 2026 - On track for $1B revenue by FY26, with strong growth, margins, and M&A execution.CGY
Investor presentation2 Apr 2026 - Double-digit growth, strong cash flow, and disciplined acquisitions drive rising shareholder value.CGY
Investor presentation2 Apr 2026 - Defence, space, and health growth drive record revenues, EBITDA, and shareholder value.CGY
Investor presentation2 Apr 2026